Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Inovio Pharmaceuticals | 2,526 | 2021 | |||||||||
Π Π-ΠΠ°ΠΏΠ°Π΄Π½Π°Ρ Π‘ΠΈΠ±ΠΈΡΡ | 44 | 2024q1 | |||||||||
Beyond Air | 50 | 2024q1 | |||||||||
Rhythm Pharmaceuticals | 1,913 | 2021 | |||||||||
Anterix | 640 | 2022 | |||||||||
BridgeBio Pharma, Inc | 5,201 | 2023 | |||||||||
Vaxart | 192 | 2023q3 | |||||||||
MicroVision | 357 | 2023q3 | |||||||||
Marker Therapeutics | 408 | 2021 | |||||||||
IGM Biosciences | 601 | 2023q3 | |||||||||
Shattuck Labs | 401 | 2023q3 | |||||||||
Liquidia | 1,086 | 2023q3 | |||||||||
Pliant Therapeutics | 877 | 2023q3 | |||||||||
Autolus Therapeutics | 575 | 2021 | |||||||||
BioXcel Therapeutics | 82 | 2022 | |||||||||
AbCellera Biologics | 1,332 | 2023q3 | |||||||||
Arrowhead Pharmaceuticals | 2,917 | 2023q3 | |||||||||
Lucid Group | 4,580 | 2021 | |||||||||
uniQure | 223 | 2023q3 | |||||||||
Hyliion Holdings | 108 | 2023q3 |